bioecon Member area
Technology · Biochemistry & industrial biotech / Specialty & fine chemicals

Sialic Acid (N-Acetylneuraminic Acid) Bioproduction

Industrial biomanufacturing of high-purity sialic acid (n-acetylneuraminic acid) bioproduction utilizing engineered microbial fermentation or biocatalytic enzyme cascades. N-acetylneuraminic acid (SA/sialic acid) 98%+ powder — infant-formula/brain-health ingredient; CABI 嘉必优's third platform pillar (E. coli fermentation route, C6 .

Leisure, Welfare & Integration Maturity 8/9 Risk: low Cosmetics US · CN · EU · RU verified 2026-11-15 · 2 Sources (2 independent)

1 · What it gives

Sialic Acid (N-Acetylneuraminic Acid) Bioproduction represents a critical node in high-value fine chemical and active pharmaceutical ingredient (API) biomanufacturing, overcoming the thermodynamic limits, toxic waste streams, and low stereoselectivity associated with legacy multi-step organometallic synthesis. Through targeted chemoenzymatic cascades, stereospecific biotransformations, and recombinant fermentation, complex chiral centers, heterocyclic scaffolds, and delicate functional intermediates are constructed under ambient conditions with near-perfect atom economy.

The technological platform integrates continuous microreactor flow biocatalysis, counter-current liquid-liquid centrifugal extraction, preparative simulated moving bed (SMB) chromatography, and agitated Nutsche filter drying (ANFD). Advanced chemical engineering systems achieve overall isolated yields exceeding 85% with optical and chemical purities surpassing 99.8%. Operations adhere strictly to ICH Q7 cGMP guidelines, ensuring mutagenic impurities and heavy metal residues remain well below 0.05% thresholds in full compliance with global pharmacopeias.

The key directions of this technology are:

  1. Chemoenzymatic Route Engineering in Sialic Acid (N-Acetylneuraminic Acid) Bioproduction: Interlocking synthetic organic chemistry with stereospecific biocatalytic steps (ketoreductases, transaminases) to truncate synthetic routes by up to 60%.
  2. Continuous Flow Microreactor Chemistry: Transitioning batch syntheses to microchannel flow reactors with immobilized enzyme monoliths, eliminating hazardous intermediate accumulation.
  3. Rigorous Impurity Profiling & Genotoxic Control: Deploying high-resolution Orbitrap LC-MS to map and purge trace mutagenic byproducts below ICH Q3A/B limits (<0.05%).
  4. Polymorph-Controlled cGMP Crystallization: Utilizing continuous oscillatory baffled crystallizers with inline FBRM monitoring to lock in stable therapeutic crystal polymorphs.

Sectoral value chain#

┌────────────────────────────────────────────────────────┐
│  Tier 1: Chiral Precursor Activation & Sourcing        │
│  (Starting materials cGMP assay & pre-activation)      │
└───────────────────────────────────┬────────────────────┘
                                    │
                                    ▼
┌────────────────────────────────────────────────────────┐
│  Tier 2: Chemoenzymatic Continuous Flow Reactor        │
│  (Immobilized enzyme microchannel with cofactor recycle│
└───────────────────────────────────┬────────────────────┘
                                    │
                                    ▼
┌────────────────────────────────────────────────────────┐
│  Tier 3: Counter-Current Centrifugal Extraction        │
│  (Multi-stage liquid-liquid organic solvent partition) │
└───────────────────────────────────┬────────────────────┘
                                    │
                                    ▼
┌────────────────────────────────────────────────────────┐
│  Tier 4: Preparative Chiral SMB Chromatography         │
│  (Simulated moving bed resolving optical antipodes)    │
└───────────────────────────────────┬────────────────────┘
                                    │
                                    ▼
┌────────────────────────────────────────────────────────┐
│  Tier 5: ANFD Controlled Crystallization & Drying      │
│  (Enclosed Nutsche filter drying & jet micronization)  │
└────────────────────────────────────────────────────────┘

Value chain levels#

LevelDescriptionKey inputs/outputs
Starting Material ActivationSynthesis, incoming compendial quality control, and dissolution of pro-chiral key starting materials (KSM).In: Commercial fine chemicals, solvents, activation reagents.
Out: Sterile, analytical-grade pro-chiral feed solution (>98.5% purity).
Continuous Flow TransformationStereospecific biotransformation in jacketed microchannel reactors containing engineered biocatalysts.In: Pro-chiral substrate, immobilized enzymes, recycled NADPH.
Out: High-conversion reaction stream (>99.0% conversion, ee >99.8%).
Liquid-Liquid Centrifugal ExtractionCounter-current multi-stage centrifugal extraction separating organic active from aqueous enzyme waste.In: Reaction effluent, pharmaceutical ethyl acetate/heptane.
Out: Concentrated organic product extract (spent enzymes separated).
Preparative SMB ChromatographyContinuous simulated moving bed chromatography on chiral stationary phases to purge trace enantiomers.In: Organic extract, mobile phase solvents.
Out: Chromatographically pure API stream (all impurities <0.10%).
Polymorph Crystallization & DryingControlled cooling crystallization, enclosed agitated Nutsche filter drying (ANFD), and jet milling.In: Purified stream, seed crystals, pharmaceutical nitrogen.
Out: Compendial-grade micronized cGMP API (>99.8% purity, Form I).

Cross-cutting technologies of the sector:

  • Enclosed Agitated Nutsche Filter Dryers (ANFD): Contained pressure filtration, multi-solvent displacement washing, and vacuum drying in a single cGMP vessel.
  • Focused Beam Reflectance Measurement (FBRM): Inline laser chord length tracking in crystallization slurries to monitor nucleation and growth kinetics in real time.

2 · What it replaces 3 · matched by industry

D1E–Fermentation cosmetic ingredients instead of shark-liver squalene, rooster-comb hyaluronic acid and animal collagen
Replaces: Shark-liver oil squalene (deep-sea shark fisheries); hyaluronic acid from rooster combs; bovine/porcine collagen extracts (and their …
COSM
D3E2Biodegradable scrub particles and exfoliants instead of polyethylene microbeads
Replaces: Polyethylene (and PP/PET/PMMA) microbeads in rinse-off cosmetics: face/body scrubs, toothpastes, shower gels; glitter (polyester/alu …
COSM
D1E–Biosurfactant and APG cleansing — sophorolipids, rhamnolipids, alkyl polyglucosides — instead of petrochemical SLES/SLS
Replaces: Petrochemical anionic surfactants (SLES/SLS) and their ethoxylated feedstock chain (1,4-dioxane contamination risk at trace levels, …
COSM

3 · How to implement 4 steps

  1. 1
    Synthesis & conversion
  2. 2
  3. 3
    Purification & downstream
  4. 4
    Purification & downstream

4 · Who delivers

Matched suppliers (matched automatically)

CABIO 嘉必优 (SSE 688089)ChinaProduceractive
CheckerspotUnited StatesProduceractive
ChainCraftNetherlandsProduceractive
KansenBio 绿色康成ChinaProduceractive
Shandong Chuangxin Humic Acid TechnologyChinaProduceractive
Kyowa Hakko Bio (Kirin)JapanProduceractive
CJ CheilJedang (CJ Biomaterials)South KoreaProduceractive
Hebei Granray Bioproducts Co.,LtdChinaProduceractive
EvonikGermanyProduceractive

Leading companies and institutes (from the brief)

Company / InstituteCountryKey products / platformsTech featuresStatus 2026
Novonesis (Novozymes)🇩🇰 DenmarkIndustrial Enzyme Platforms & Microbial SolutionsStandardized cGMP / ISO 9001 biocatalytic validation and high-titer downstream isolation.Commercial Scale
Codexis🇺🇸 United StatesCodeEvolver Directed Evolution & API BiocatalystsStandardized cGMP / ISO 9001 biocatalytic validation and high-titer downstream isolation.Commercial Scale
BASF🇩🇪 GermanyIntegrated Chemical & Biocatalytic SynthesisStandardized cGMP / ISO 9001 biocatalytic validation and high-titer downstream isolation.Commercial Scale
Enzymaster🇨🇳 ChinaEngineered Biocatalysts & Chiral Fine ChemicalsStandardized cGMP / ISO 9001 biocatalytic validation and high-titer downstream isolation.Commercial Scale
Lonza🇨🇭 SwitzerlandMicrobial CDMO & Custom Biocatalysis PlatformsStandardized cGMP / ISO 9001 biocatalytic validation and high-titer downstream isolation.Commercial Scale
Evonik Industries🇩🇪 GermanyFermentation Biosurfactants & Specialty IntermediatesStandardized cGMP / ISO 9001 biocatalytic validation and high-titer downstream isolation.Commercial Scale

5 · Rules & route to market

Route into Russia / EAEU: COSM · EAEU conformity bodies (Rospotrebnadzor for SGR)
declaration (SGR for some categories)
Information, not legal advice — confirm the procedure for your product. (2026-10-06)
United States

FDA CDER cGMP compliance, Type II Drug Master File (DMF), BARDA critical onshoring#

  • FDA 21 CFR Part 210/211 cGMP Compliance: Comprehensive operational validation and quality assurance for active pharmaceutical manufacturing of Sialic Acid (N-Acetylneuraminic Acid) Bioproduction.
  • Type II Drug Master File (DMF) Submission: Full chemistry, manufacturing, and controls (CMC) documentation supported by ICH stability data.
  • BARDA Critical Pharmaceutical Onshoring: Federal strategic support targeting domestic continuous-flow manufacturing of essential medical ingredients.

European Union

EMA Active Substance Master File (ASMF), EDQM CEP certification, Critical Medicines Alliance#

  • EMA & EDQM CEP Certification: Issuance of Certificates of Suitability demonstrating adherence to European Pharmacopoeia (Ph. Eur.) standards.
  • EU Critical Medicines Alliance Support: Strategic public investments to de-risk green biocatalytic synthesis routes for essential medicines.
  • ECHA REACH & Industrial Emissions Directive (IED): Strict solvent recovery mandates and volatile organic compound (VOC) emissions abatement.

China

14th Five-Year Bioeconomy Strategy, National Medical Products Administration (NMPA) GMP, ChP 2025#

  • Green Pharmaceutical Manufacturing Priority: Strategic industrialization of 唾液酸(N-乙酰神经氨酸 / 燕窝酸)全酶法或发酵制造 within API hubs across Zhejiang, Jiangsu, and Shandong.
  • NMPA Drug Platform Registration & Audits: Mandatory registration on the National Drug Intermediate Platform and dynamic cGMP on-site inspections.
  • Chinese Pharmacopoeia (ChP) Compliance: Rigorous control of related substances, genotoxic impurities, and residual solvents under compendial monographs.

6 · Money: tenders & grants

No open tender or grant matched right now.

7 · Tech stack & innovations

  1. Chemoenzymatic Cascade Design in Sialic Acid (N-Acetylneuraminic Acid) Bioproduction:
    • Coupled ketoreductase and transaminase cascades installing complex chiral centers with absolute stereochemical control (ee >99.8%).
    • Computational retrosynthetic route truncation reducing total synthetic step count from 8 chemical stages to 3 biocatalytic operations.
  2. Microreactor Flow Chemistry & Extraction:
    • Hastelloy continuous flow microchannels providing exceptional heat transfer rates (>10,000 W/m²·K) for exothermic biotransformations.
    • Multi-stage counter-current centrifugal liquid-liquid extractors achieving complete product recovery with low solvent consumption.
  3. Continuous SMB Chromatography & Crystallization:
    • Industrial simulated moving bed (SMB) chiral column trains resolving optical antipodes with solvent recovery exceeding 95%.
    • Automated continuous oscillatory baffled crystallizers (COBC) utilizing inline FBRM probes to enforce metastable zone width control.

Sources 2 · 2 independent · 0 producer sites

Independent sources 2

  1. www.ncbi.nlm.nih.gov research checked 2026-11-15
  2. doi.org research checked 2026-11-15